Gait Speed at Discharge as a Marker for Readmission

All Disease That May Require Acute Hospitalization Except for Phsychiatric Disease Clinical Trial

— GASP  

Official title:

Gait Speed at Discharge as a Marker for Readmission - The GASP Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03049865
• Other study ID #: Dnr 2016/2174-31
• Status: Not yet recruiting
• Phase: N/A
• First received: February 8, 2017
• Last updated: February 9, 2017
• Start date: February 9, 2017
• Est. completion date: December 31, 2027

Study information

• Verified date: February 2017
• Source: Karolinska University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The principal aim is to assess if a simple test, the time it takes to walk 10 meters for a patient about to be discharged after a hospital stay for an acute illness, is related to the risk of readmission.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1000
• Est. completion date: December 31, 2027
• Est. primary completion date: December 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 51 Years and older

Eligibility

Inclusion Criteria:

• >50 years of age Patient discharged to home, or temporary short stay nursing home Expected survival >90 days The ability to read or understand the instructions and to give informed consent.

Exclusion Criteria:

• Planned hospital stay, i.e. the patient was admitted electively The including investigator is directly involved in the care of the patient

Related Conditions & MeSH terms

• All Disease That May Require Acute Hospitalization Except for Phsychiatric Disease

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Readmission		30 days
Secondary	Readmissions		90,180, 365 days
Secondary	All-cause mortality		6, 12, 24, 36, 60 months